New Blood Test Detects Womb Cancer Recurrence

0:00A new blood test for detecting wound cancer recurrence is on track for nationwide rollout in the UK after strong trial results from Lester. Called the E.C. key DNA test, it spots tiny cancer fragments in the blood and was developed over eight years by the University of Lester and local NHS. Hospitals. Wound Cancer, which begins in the uterus lining, ranks as the fourth most common cancer among women. This non-invasive approach promises quicker detection of cancer coming back, skipping painful biopsies and pelvic exams that distress many patients. Doctors say it also reveals genetic details about the cancer, helping tailor treatments more effectively. The trial involved more than 85 women with endometrial cancer, showing real potential to replace uncomfortable checkups, especially for those who find physical exams too tough. One patient, an 80-year-old from Lester, named Gillian Stacey, beat grimads. She was given six months to live 11 years ago, but fought, through surgery, chemo, radiation,

1:02and ongoing therapy after recurrence in her lungs. She credits her doctor for saving her and welcomes any less invasive option. Researchers are now pushing through final validation and quality checks at the Lester Biomedical Research Center paving the way for this. Some changing test to hit everyday clinic soon and ease the burden on survivors everywhere. Lester News Today, powered by AI Bringing You What Matters, I'm Corey with The Story.